13F HOLDINGS REPORT
Artia Global Partners LP
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0001937964-24-000005
Total Value
$517.3M
Positions
46
Other Managers
0
Confidential Omitted
No
Holdings (46)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | NOVO-NORDISK A S | NONOF | 691,743 | $98.7M | 19.09% |
| 2 | ELI LILLY & CO | LLY | 92,593 | $83.8M | 16.20% |
| 3 | ELI LILLY & CO | LLY | 75,000 | $67.9M | 13.13% |
| 4 | MERCK & CO INC | MRK | 442,504 | $54.8M | 10.59% |
| 5 | NOVO-NORDISK A S | NONOF | 310,000 | $44.2M | 8.55% |
| 6 | VIKING THERAPEUTICS INC | VKTX | 452,979 | $24.0M | 4.64% |
| 7 | ASTRAZENECA PLC | AZN | 190,752 | $14.9M | 2.88% |
| 8 | INTRA-CELLULAR THERAPIES INC | 46116X101 | 216,519 | $14.8M | 2.87% |
| 9 | VERTEX PHARMACEUTICALS INC | VRTX | 18,900 | $8.9M | 1.71% |
| 10 | ALNYLAM PHARMACEUTICALS INC | ALNY | 35,000 | $8.5M | 1.64% |
| 11 | VIKING THERAPEUTICS INC | VKTX | 150,000 | $8.0M | 1.54% |
| 12 | INSMED INC | INSM | 110,000 | $7.4M | 1.42% |
| 13 | AXSOME THERAPEUTICS INC | AXSM | 87,848 | $7.1M | 1.37% |
| 14 | ARGENX SE | ARGX | 15,138 | $6.5M | 1.26% |
| 15 | NEUROCRINE BIOSCIENCES INC | NBIX | 45,000 | $6.2M | 1.20% |
| 16 | VAXCYTE INC | PCVX | 76,255 | $5.8M | 1.11% |
| 17 | PROTAGONIST THERAPEUTICS INC | PTGX | 124,440 | $4.3M | 0.83% |
| 18 | DYNE THERAPEUTICS INC | DYN | 119,488 | $4.2M | 0.82% |
| 19 | SOLENO THERAPEUTICS INC | SLNO | 94,424 | $3.9M | 0.74% |
| 20 | CRINETICS PHARMACEUTICALS IN | CRNX | 85,765 | $3.8M | 0.74% |
| 21 | INSMED INC | INSM | 53,436 | $3.6M | 0.69% |
| 22 | OCULAR THERAPEUTIX INC | OCUL | 500,000 | $3.4M | 0.66% |
| 23 | IONIS PHARMACEUTICALS INC | IONS | 62,479 | $3.0M | 0.58% |
| 24 | MERUS N V | N5749R100 | 50,171 | $3.0M | 0.57% |
| 25 | CELLDEX THERAPEUTICS INC NEW | CLDX | 75,300 | $2.8M | 0.54% |
| 26 | APOGEE THERAPEUTICS INC | APGE | 58,400 | $2.3M | 0.44% |
| 27 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 53,930 | $2.0M | 0.39% |
| 28 | IDEAYA BIOSCIENCES INC | IDYA | 54,392 | $1.9M | 0.37% |
| 29 | VERONA PHARMA PLC | 925050106 | 130,790 | $1.9M | 0.37% |
| 30 | XENON PHARMACEUTICALS INC | XENE | 40,000 | $1.6M | 0.30% |
| 31 | MEREO BIOPHARMA GROUP PLC | MREO | 421,359 | $1.5M | 0.29% |
| 32 | CHARLES RIV LABS INTL INC | 159864107 | 6,905 | $1.4M | 0.28% |
| 33 | KURA ONCOLOGY INC | KURA | 57,178 | $1.2M | 0.23% |
| 34 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 54,285 | $1.0M | 0.20% |
| 35 | ASCENDIS PHARMA A/S | ASND | 7,440 | $1.0M | 0.20% |
| 36 | SILENCE THERAPEUTICS PLC | SLNCF | 52,476 | $997,044 | 0.19% |
| 37 | SYNDAX PHARMACEUTICALS INC | SNDX | 48,263 | $990,839 | 0.19% |
| 38 | KEROS THERAPEUTICS INC | KROS | 20,000 | $914,000 | 0.18% |
| 39 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 20,000 | $905,000 | 0.17% |
| 40 | EYEPOINT PHARMACEUTICALS INC | EYPT | 101,500 | $883,050 | 0.17% |
| 41 | ANNEXON INC | ANNX | 147,485 | $722,677 | 0.14% |
| 42 | LARIMAR THERAPEUTICS INC | LRMR | 90,490 | $656,053 | 0.13% |
| 43 | DISC MEDICINE INC | IRON | 13,440 | $605,741 | 0.12% |
| 44 | PLIANT THERAPEUTICS INC | PLRX | 50,000 | $537,500 | 0.10% |
| 45 | MADRIGAL PHARMACEUTICALS INC | MDGL | 1,557 | $436,209 | 0.08% |
| 46 | SAREPTA THERAPEUTICS INC | SRPT | 2,600 | $410,800 | 0.08% |